104 related articles for article (PubMed ID: 26390734)
1. [SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].
Gavrilina OA; Zvonkov EE; Biderman BV; Severina NA; Parovichnikova EN
Ter Arkh; 2015; 87(7):105-111. PubMed ID: 26390734
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.
Mareschal S; Dubois S; Viailly PJ; Bertrand P; Bohers E; Maingonnat C; Jaïs JP; Tesson B; Ruminy P; Peyrouze P; Copie-Bergman C; Fest T; Jo Molina T; Haioun C; Salles G; Tilly H; Lecroq T; Leroy K; Jardin F
Genes Chromosomes Cancer; 2016 Mar; 55(3):251-67. PubMed ID: 26608593
[TBL] [Abstract][Full Text] [Related]
3. SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Schif B; Lennerz JK; Kohler CW; Bentink S; Kreuz M; Melzner I; Ritz O; Trümper L; Loeffler M; Spang R; Möller P
Oncotarget; 2013 Jan; 4(1):35-47. PubMed ID: 23296022
[TBL] [Abstract][Full Text] [Related]
4. B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study.
Xu PP; Zhong HJ; Huang YH; Gao XD; Zhao X; Shen Y; Cheng S; Huang JY; Chen SJ; Wang L; Zhao WL
EBioMedicine; 2017 Feb; 16():106-114. PubMed ID: 28153771
[TBL] [Abstract][Full Text] [Related]
5. BCL2 mutations in diffuse large B-cell lymphoma.
Schuetz JM; Johnson NA; Morin RD; Scott DW; Tan K; Ben-Nierah S; Boyle M; Slack GW; Marra MA; Connors JM; Brooks-Wilson AR; Gascoyne RD
Leukemia; 2012 Jun; 26(6):1383-90. PubMed ID: 22189900
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of diffuse large B-cell lymphoma.
Lossos IS
J Clin Oncol; 2005 Sep; 23(26):6351-7. PubMed ID: 16155019
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
8. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.
Mottok A; Renné C; Seifert M; Oppermann E; Bechstein W; Hansmann ML; Küppers R; Bräuninger A
Blood; 2009 Nov; 114(20):4503-6. PubMed ID: 19734449
[TBL] [Abstract][Full Text] [Related]
9. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma.
Wohlfart S; Sebinger D; Gruber P; Buch J; Polgar D; Krupitza G; Rosner M; Hengstschläger M; Raderer M; Chott A; Müllauer L
Am J Pathol; 2004 Mar; 164(3):1081-9. PubMed ID: 14982861
[TBL] [Abstract][Full Text] [Related]
10. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
12. Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.
Capello D; Gloghini A; Baldanzi G; Martini M; Deambrogi C; Lucioni M; Piranda D; Famà R; Graziani A; Spina M; Tirelli U; Paulli M; Larocca LM; Gaidano G; Carbone A; Sinigaglia F
Hematol Oncol; 2013 Mar; 31(1):22-8. PubMed ID: 22488585
[TBL] [Abstract][Full Text] [Related]
13. [Diffuse large B-cell lymphoma: therapeutic development based on clinical and biological heterogeneity].
Miyazaki K
Rinsho Ketsueki; 2015 Oct; 56(10):2047-55. PubMed ID: 26458444
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
15. [Genetic heterogeneity of DLBCL, not otherwise specified].
Karube K
Rinsho Ketsueki; 2017; 58(6):669-675. PubMed ID: 28680000
[TBL] [Abstract][Full Text] [Related]
16. Mutations within the 5' region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma.
Scholl V; Stefanoff CG; Hassan R; Spector N; Renault IZ
Leuk Lymphoma; 2007 May; 48(5):957-63. PubMed ID: 17487740
[TBL] [Abstract][Full Text] [Related]
17. Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.
Bohers E; Mareschal S; Bertrand P; Viailly PJ; Dubois S; Maingonnat C; Ruminy P; Tilly H; Jardin F
Leuk Lymphoma; 2015 May; 56(5):1213-22. PubMed ID: 25130477
[TBL] [Abstract][Full Text] [Related]
18. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
19. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma.
Schmid CA; Robinson MD; Scheifinger NA; Müller S; Cogliatti S; Tzankov A; Müller A
J Exp Med; 2015 May; 212(5):775-92. PubMed ID: 25847947
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
